News | November 03, 2021
Venus Remedies H1 net profit rises 315%
Venus Remedies has reported consolidated financial results for the period ended September 30, 2021
Venus Remedies has reported consolidated financial results for the period ended September 30, 2021
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
Gini Health works in the domain of personalised healthcare
Acute therapies continue to report strong growth compared to chronic ones.
This strategic collaboration will enable continued innovation in cancer care
The company’s wide therapeutic portfolio helped to sustain growth despite changing market demand
U.S. FDA has accepted the investigational new drug application for phase 1 clinical trial in non-Hodgkin’s lymphoma
Everlife leads the series A round, and SPRIM Global Investments participates in the financing syndicate
The company’s pharmaceutical API products Ibuprofen and fenofibrate got the go-ahead
Subscribe To Our Newsletter & Stay Updated
